Travere Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Travere Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Travere Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$54.8M, a 136% decline year-over-year.
  • Travere Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$351M, a 304% decline year-over-year.
  • Travere Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$111M, a 60% increase from 2022.
  • Travere Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$278M, a 54.6% decline from 2021.
  • Travere Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$180M, a 6.29% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$111M +$167M +60% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 -$278M -$98.4M -54.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 -$180M -$10.7M -6.29% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 -$169M -$23M -15.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 -$146M -$43.7M -42.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$103M -$42.9M -71.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$59.7M -$11.8M -24.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 -$47.9M -$165M -141% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 $117M +$228M Jan 1, 2015 Dec 31, 2015 10-K/A 2018-07-06
2014 -$111M -$76.3M -220% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 -$34.6M -$4.28M -14.1% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 -$30.3M -$30.3M Jan 1, 2012 Dec 31, 2012 10-K/A 2015-07-09
2011 -$14.8K* +$8.2K Mar 2, 2011 Feb 29, 2012 10-K 2012-05-24
2010 -$23K* Mar 1, 2010 Feb 28, 2011 10-K 2012-05-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.